Floatz logo

Therapeutic Asset Ratings

435 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Chronic Myeloid Leukemia
OHSU Knight Cancer InstituteP3BB (67)
Niraparib
Breast Carcinoma
OHSU Knight Cancer InstituteP3BB (67)
Carboplatin
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer InstituteP2BB (67)
Carboplatin
Sarcoma
OHSU Knight Cancer InstituteP2BB (67)
Irinotecan
Relapsing Chronic Myelogenous Leukemia
OHSU Knight Cancer InstituteP2BB (67)
Vinorelbine
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer InstituteP2BB (67)
Capecitabine
Ovarian Carcinoma
OHSU Knight Cancer InstituteP3BB (66)
Letrozole
Ovarian Carcinoma
OHSU Knight Cancer InstituteP3BB (66)
TAMOXIFEN
Ovarian Carcinoma
OHSU Knight Cancer InstituteP3BB (66)
Zofran
Acute Myeloid Leukemia
OHSU Knight Cancer InstituteP3BB (66)
Carboplatin
Recurrent Prostate Carcinoma
OHSU Knight Cancer InstituteP2BB (66)
Dasatinib
Malignant Pancreatic Neoplasm
OHSU Knight Cancer InstituteP2BB (66)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Borderline Resectable Pancreatic Ductal Adenocarcinoma
OHSU Knight Cancer InstituteP2BB (66)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Pancreatic Ductal Adenocarcinoma
OHSU Knight Cancer InstituteP2BB (66)
Niraparib
Stage IV Pancreatic Cancer AJCC v8
OHSU Knight Cancer InstituteP2BB (66)
Pembrolizumab
Acute Lymphoblastic Leukemia
OHSU Knight Cancer InstituteP2BB (66)
Vinorelbine
Recurrent Prostate Carcinoma
OHSU Knight Cancer InstituteP2BB (66)
Vinorelbine
Stage III Pancreatic Cancer AJCC v8
OHSU Knight Cancer InstituteP2BB (66)
Panobinostat
Primary Myelofibrosis
OHSU Knight Cancer InstituteP4BB (65)
Abemaciclib
Ovarian Carcinoma
OHSU Knight Cancer InstituteP2BB (65)
Gdc-0449
Malignant Pancreatic Neoplasm
OHSU Knight Cancer InstituteP2BB (65)
Ruxolitinib
Myelodysplastic/Myeloproliferative Neoplasm
OHSU Knight Cancer InstituteP2BB (65)
TRASTUZUMAB
Ovarian Carcinoma
OHSU Knight Cancer InstituteP2BB (65)
PIFLUFOLASTAT
Castration-Resistant Prostate Carcinoma
OHSU Knight Cancer InstituteP4BB (64)
Bortezomib
Non-Hodgkin Lymphoma
OHSU Knight Cancer InstituteP3BB (64)
Showing 26 to 50 of 435 assets
PreviousPage 2 of 18Next